AMEX · Drug Manufacturers - Specialty & Generic

China Pharma Holdings, Inc. (CPHI) Stock

$0.96 +12.94% AMEX: CPHI Healthcare

Valuation

MetricValue
Price$0.96
Market Cap$38.90M
P/E Ratio-0.65
P/B Ratio0.08
P/S Ratio6.76
EPS (TTM)$0.00
52-Week High$19.19
52-Week Low$0.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-17.14%
ROA-10.01%
ROCE-11.82%
Gross Margin-75.00%
Operating Margin-75.00%
Net Margin-114.33%
Debt/Equity0.10
Current Ratio0.32

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$8.0M$7.0M$5.0M$4.0M
Operating Profit$-3.0M$-4.0M$-3.0M$-5.0M$-3.0M
Net Profit$-3.0M$-4.0M$-3.0M$-5.0M$-3.0M
EPS$-0.85$-1.94$-0.29$-0.27$-0.74
Op Margin-29.7%-43.8%-39.3%-101.3%-74.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$18.0M$16.0M$15.0M$31.0M
Total Liabilities$17.0M$13.0M$9.0M$7.0M$8.0M
Cash$5.0M$2.0M$1.0M$1.0M$0
Borrowings$12.0M$9.0M$5.0M$4.0M$4.0M

Latest News

Top Midday Decliners MT Newswires · Jul 22, 2026 China Pharma Announces Pricing of $5 Million Registered Direct Offering PR Newswire · Jul 22, 2026 China Pharma Holdings, Inc. Comments on Unusual Market Activity PR Newswire · Jul 21, 2026 China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity PR Newswire · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$0$0
Investing Cash Flow$-1.0M$-1.0M$0$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$4.0M$-3.0M$-1.0M$-1.0M$0
Free Cash Flow$-1.0M$-1.0M$-1.0M$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-20.76
FCF Yield-0.83%
Quick Ratio0.08
Interest Coverage-44.20
Return 1Y-35.29%
Return 3Y-93.89%
Return 5Y-99.69%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMIXAutonomix Medical, Inc. $3.12 -0.32% -0.08 $1.69M 0.00%
ENSCEnsysce Biosciences, Inc. $0.46 +6.66% -0.16 $7.04M 0.00%
FLGCFlora Growth Corp. $7.79 -32.14% -0.54 $4.23M 0.00%
KALAKALA BIO, Inc. $0.30 -17.61% -0.01 $5.74M 0.00%
OGENOragenics Inc. $0.47 +2.29% -0.14 $2.14M 0.00%

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is led by CEO Zhilin Li, employs 224 people, headquartered in CN, publicly traded since 2002.

China Pharma Holdings, Inc. (CPHI) stock trades at $0.96 with a market capitalization of $38.90M. The stock is valued at a price-to-earnings (P/E) ratio of -0.65, price-to-book of 0.08, price-to-sales of 6.76. Over the past 52 weeks the stock has ranged between $0.38 and $19.19, and currently trades 95.0% below its 52-week high.

On profitability, China Pharma Holdings, Inc. generates a return on equity (ROE) of -17.14%, return on capital employed of -11.82%, an operating margin of -75.00%, a net profit margin of -114.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1177.49 +0.67% JNJ Johnson & Johnson $260.66 +1.63% ABBV AbbVie Inc. $277.31 +1.80% MRK Merck & Company, Inc. Common Stock (new) $145.87 +2.45% UNH UnitedHealth Group Incorporated Common Stock (DE) $376.88 +1.60% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $659.76 +1.19% AMGN Amgen Inc. $413.31 +1.44% GILD Gilead Sciences, Inc. $150.98 +2.64% ABT Abbott Laboratories $99.45 +0.97% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides